Cipher Pharmaceuticals Inc.TSX: CPH

Cipher Receives Health Canada Approval of (Pr)Beteflam(TM)

· Issued by Cipher Pharmaceuticals Inc. via CNW

On 6ix: 6ix.com/news/cipher-receives-health-canada-approval-of-prbeteflamtm

Watch Cipher Pharmaceuticals' latest callCipher Pharmaceuticals (TSX:CPH) Q2 2026 Earnings Call · Replay · Aug 12Read the transcript of Cipher Pharmaceuticals (TSX:CPH) Q2 2026 Earnings Call

Investors: In Canada: Craig Armitage, LodeRock Advisors, (416) 347-8954, craig.armitage@loderockadvisors.com; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, thoffmann@troutgroup.com; Media: Mike Beyer, Sam Brown Inc., (312) 961-2502, mikebeyer@sambrown.comCopyright CNW Group 2015

View original source (CNW)Cipher Pharmaceuticals Inc. on 6ix

Story so far

Earlier from Cipher Pharmaceuticals

Later from Cipher Pharmaceuticals

All Cipher Pharmaceuticals news releases